STOCK TITAN

XChange TEC.INC (XHG) Financials

XHG
FY2025 annual
Revenue $51.3M +24.9% YoY
Net Income -$105.1M -225.3% YoY
EPS (Diluted) $0.00 YoY not available
Operating Cash Flow -$1.6M -17.9% YoY
Market Cap $117.5M as of Oct 10, 2026
Price / Sales 2.3x on $51.3M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Mar 31, 2026 Reported Currency USD FYE September

Newest figures come from the 6-K for Q2 FY2026, filed Jul 16, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the XHG SEC filings page.

XChange TEC.INC (XHG) reported $51.3M in revenue for fiscal year 2025, up 24.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI XHG FY2025

Sales have returned somewhat, but thin margins and financing-dependent cash flow leave the business balance-sheet constrained.

Operating cash flow remained modestly negative in both FY2024 and FY2025, while FY2024 reported a net loss of $32.3M; that gap indicates accounting charges or other non-cash items drove much of the reported loss rather than equivalent day-to-day cash use. The business therefore appears cash-lighter in its operations than its income statement suggests, though still dependent on outside funding.

FY2025 revenue reached $51.3M, yet gross margin fell to 2.2%, so the rebound did not rebuild a meaningful contribution pool. More sales were not producing better underlying economics, pointing away from fixed-cost absorption as the primary benefit of growth.

Short-term liquidity is persistently tight: the current ratio slipped from 0.05x in FY2024 to 0.04x in FY2025, while liabilities exceeded assets and equity remained negative at -$123.6M. Financing cash flow of $2.6M accompanied operating cash flow of -$1.6M in FY2025, and the same relationship appeared in FY2024, indicating that external funding helped offset operating cash needs.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

XChange TEC.INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
2/7

XChange TEC.INC passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

XChange TEC.INC reported a net loss of $105.1M while operations used $1.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

XChange TEC.INC reported an operating loss of $101.2M against $3.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$644K
YoY-4.5%
QoQ-57.9%

XChange TEC.INC held $644K in cash as of Q2 2026; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Shares Outstanding

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

XHG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XHG quarterly income statement
MetricQ2'266-KQ4'2520-FQ2'256-KQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

XHG Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XHG quarterly balance sheet
MetricQ2'266-KQ4'2520-FQ2'256-KQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-K
Total Assets$9.4M-40.7%$9.7M-91.3%$15.9M-91.4%$111.6M+850.2%$185.9M+147.7%$11.7M-12.6%$75.0M+227.7%$13.4M-77.1%
Current Assets$5.2M-16.2%$5.6M-41.9%$6.2M-14.0%$9.6M-17.9%$7.2M-43.5%$11.7M+17.4%$12.7M+8.2%$10.0M-63.5%
Cash & Equivalents$644K-4.5%$1.5M+32.6%$674K-30.7%$1.2M+2251.0%$973K+194.0%$49K-87.4%$331K-73.7%$390K-84.6%
Short-Term Investments$335K+42.6%$266K-8.3%$235K+1.7%$290K$231K$0$0$0
Accounts Receivable$3.3M+10.3%$3.3M-36.3%$3.0M-11.6%$5.2M$3.4M+910.1%N/A$335K$106K+86.0%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$3.4M-61.9%$3.3M-96.8%$8.9M-95.0%$101.1M$177.9MN/AN/AN/A
Total Liabilities$135.8M-25.9%$133.4M-30.1%$183.3M-15.5%$190.9M+91.0%$217.0M+32.6%$99.9M+6.3%$163.7M-63.8%$94.0M-78.8%
Current Liabilities$135.7M-25.9%$133.3M-30.1%$183.3M-15.5%$190.8M$217.0M+59.3%N/A$136.2M-65.9%$94.0M-74.2%
Non-Current Liabilities$37K-33.9%$50K-40.5%$56K+16.7%$84K$48K-99.8%N/A$27.5M-47.7%$0-100.0%
Total Equity-$126.3M+24.5%-$123.6M-55.9%-$167.4M-438.1%-$79.3M+10.1%-$31.1M+64.9%-$88.2M-9.5%-$88.6M+79.4%-$80.5M+79.2%
Retained Earnings-$670.2M-7.3%-$646.9M-17.7%-$624.9M-39.1%-$549.6M-10.5%-$449.1M+14.4%-$497.5M+0.5%-$524.5M+28.1%-$500.3M+26.4%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

XHG Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XHG quarterly cash flow statement
MetricQ2'266-KQ4'2520-FQ2'256-KQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

XHG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XHG quarterly financial ratios
MetricQ2'266-KQ4'2520-FQ2'256-KQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-K
Current Ratio0.040.0x0.040.0x0.030.0x0.050.03-0.1xN/A0.09+0.1x0.110.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$123.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
XChange TEC.INC XHG FY2025 $51.3M -$105.1M N/A $117.5M —
GoHealth, Inc. GOCO FY2025 $361.8M -$257.1M -71.1% $5.1M 10/100
eHealth, Inc. EHTH FY2025 $554.0M $40.0M 7.2% $22.4M 18/100
AIFU Inc. AIFU FY2025 $79.6M -$325.4M N/A $71.2M 23/100
TIAN RUIXIANG Holdings Ltd TIRX FY2024 $5.4M $617K 11.4% $2.7M 24/100
TWFG, Inc. TWFG FY2025 $248.5M $41.2M 16.6% $318.9M 10/100

Frequently Asked Questions

What is XChange TEC.INC's annual revenue?

XChange TEC.INC (XHG) reported $51.3M in total revenue for fiscal year 2025. This represents a 24.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is XChange TEC.INC's revenue growing?

XChange TEC.INC (XHG) revenue grew by 24.9% year-over-year, from $41.1M to $51.3M in fiscal year 2025.

Is XChange TEC.INC profitable?

No, XChange TEC.INC (XHG) reported a net income of -$105.1M in fiscal year 2025.

XChange TEC.INC (XHG) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

XChange TEC.INC (XHG) had a gross margin of 2.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

XChange TEC.INC (XHG) recorded an outflow of $1.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

XChange TEC.INC (XHG) had $9.7M in total assets as of fiscal year 2025, including both current and long-term assets.

XChange TEC.INC (XHG) had a current ratio of 0.04 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

XChange TEC.INC (XHG) had a return on assets of -1078.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

XChange TEC.INC (XHG) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $117.5M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

XChange TEC.INC (XHG) trades at 2.3x sales, its market capitalization divided by revenue of $51.3M revenue, FY2025. The market capitalization is $117.5M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

XChange TEC.INC (XHG) has negative shareholder equity of -$123.6M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

XChange TEC.INC (XHG) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

XChange TEC.INC (XHG) reported a net loss of $105.1M while operations used $1.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

XChange TEC.INC (XHG) reported an operating loss of $101.2M against $3.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top